PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: Medicare
Budget policies jeopardize FDA funding, user fees
Budget policies jeopardize FDA funding, user fees
Even though Congress authorized both existing and new user fees for the Food and Drug Administration several months ago through the FDA Safety & Innovation Act (FDASIA), efforts to cut the federal deficit raises questions about how those fees will be collected and used in the coming year. FDA, [...]
Posted in FDA, Guest Blog, Regulatory Also tagged CR, FDA, FDA safety and innovation act, GDUFA, Regulatory, Washington Leave a comment
Affordable Care Act: Where's the Sunshine?
Where’s the Sunshine?
The Senate Special Committee on Aging is holding a Roundtable discussion on Wed. Sept. 12, 2012 in hopes of spurring action to implement the “Sunshine” provisions of the Affordable Care Act (ACA). Policies for collecting and submitting information on pharma payments to doctors were supposed to be issued by last September (2011), so [...]
Posted in Guest Blog, Op-Ed, Regulatory, healthcare Also tagged Affordable Care Act, healthcare reform, Medicaid, Sunshine Act Leave a comment
Supreme Court Considers the Affordable Care Act
Posted in Corporate Responsibility, Legal, Regulatory, Strategy, healthcare Also tagged Democrats, generics, healthcare reform, Medicaid, Politics, republican, Republicans, United States Supreme Court Leave a comment
Got Ideas About Medicare and Medicaid Reform?
The Center for Medicare and Medicaid Innovation (CMMI) is now accepting applications for its Innovation Advisors Program. The CMMI, created by the Affordable Care Act, is tasked with “testing new models of healthcare delivery and payment.”
Posted in FDA, Regulatory, Strategy, healthcare, leadership Also tagged CMS, Medicaid Leave a comment
Sequestration: What Does it Mean for Pharma?